Sittner & Nelson’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.9K Hold
690
0.02% 271
2026
Q1
$64.5K Hold
690
0.02% 274
2025
Q4
$69.2K Hold
690
0.02% 247
2025
Q3
$61.1K Hold
690
0.02% 237
2025
Q2
$59.4K Hold
690
0.02% 238
2025
Q1
$62.9K Hold
690
0.03% 215
2024
Q4
$59.3K Hold
690
0.03% 210
2024
Q3
$67.7K Hold
690
0.03% 205
2024
Q2
$64.1K Hold
690
0.03% 190
2024
Q1
$64.3K Hold
690
0.03% 192
2023
Q4
$59.8K Hold
690
0.03% 197
2023
Q3
$56.9K Hold
690
0.03% 193
2023
Q2
$58.6K Hold
690
0.03% 195
2023
Q1
$57.5K Hold
690
0.03% 206
2022
Q4
$58.6K Hold
690
0.04% 204
2022
Q3
$52K Hold
690
0.03% 201
2022
Q2
$56K Hold
690
0.04% 204
2022
Q1
$60K Hold
690
0.03% 193
2021
Q4
$62K Hold
690
0.04% 188
2021
Q3
$58K Hold
690
0.04% 180
2021
Q2
$57K Hold
690
0.04% 168
2021
Q1
$53K Hold
690
0.04% 166
2020
Q4
$53K Buy
+690
New +$50.8K 0.05% 157

Other funds holding IXJ

Sittner & Nelson's IXJ Position: Q2 2026 in Review

Sittner & Nelson held its iShares Global Healthcare ETF (IXJ) position steady in Q2 2026 at 690 shares worth $67.9K. The position accounts for 0.02% of the portfolio, ranked #271.

Sittner & Nelson first reported a position in IXJ in Q4 2020 and has held it in 23 quarters since. The position peaked at $69.2K in Q4 2025. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Sittner & Nelson held 690 shares of iShares Global Healthcare ETF worth $67.9K as of Q2 2026.
  • Sittner & Nelson left its iShares Global Healthcare ETF share count unchanged in Q2 2026.
  • iShares Global Healthcare ETF made up 0.02% of Sittner & Nelson's portfolio in Q2 2026, its #271 holding.
  • Sittner & Nelson first reported a position in iShares Global Healthcare ETF in Q4 2020 and has held it in 23 quarters since.
  • Sittner & Nelson's iShares Global Healthcare ETF position peaked at $69.2K in Q4 2025.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.